Factors associated with tuberculosis treatment outcomes among TB patients aged 15 years and older at chawama level one hospital in Lusaka, Zambia

References

• Afshar, B., Carless, J., Roche, A., Balasegaram, S., & Anderson, C. (2019). Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002-2015. PLoS One, 14(2), e0211972. https://doi.org/10.1371/journal.pone.0211972
   PubMed Web of Science ®Google Scholar
• Akanbi, K., Ajayi, I., Fayemiwo, S., Gidado, S., Oladimeji, A., & Nsubuga, P. (2019). Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in abeokuta, ogun state, Nigeria. Pan African Medical Journal, 32(Suppl 1), 7. https://doi.org/10.11604/pamj.supp.2019.32.1.13272
   PubMedGoogle Scholar
• Alao, M. A., Maroushek, S. R., Chan, Y. H., Asinobi, A. O., Slusher, T. M., & Gbadero, D. A. (2020). Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center. PLoS One, 15(10), e0239225. https://doi.org/10.1371/journal.pone.0239225
   PubMed Web of Science ®Google Scholar
• Baluku, J. B., Mugabe, P., Mulwana, R., Nassozi, S., Katuramu, R., & Worodria, W. (2020). High prevalence of rifampicin resistance associated with rural residence and very low bacillary load among TB/HIV-coinfected patients at the national tuberculosis treatment center in Uganda. BioMed Research International, 2020, 1–7. https://doi.org/10.1155/2020/2508283
   Web of Science ®Google Scholar
• Burnett, S. M., Zawedde-Muyanja, S., Hermans, S. M., Weaver, M. R., Colebunders, R., & Manabe, Y. C. (2018). Effect of TB/HIV integration on TB and HIV indicators in rural Ugandan health facilities. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79(5), 605–611. https://doi.org/10.1097/QAI.0000000000001862
   PubMed Web of Science ®Google Scholar
• CDCTB. (2023, October 20). Tuberculosis (TB)—Treatment of LTBI and TB for Persons with HIV. Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/treatment/tbhiv.htm.
   Google Scholar
• Chidambaram, V., Tun, N. L., Majella, M. G., Castillo, J. R., Ayeh, S. K., Kumar, A., Neupane, P., Sivakumar, R. K., Win, E. P., Abbey, E. J., Wang, S., Zimmerman, A., Blanck, J., Gupte, A., Wang, J.-Y., & Karakousis, P. C. (2021). Sex differences in TB treatment outcomes: Retrospective cohort study and meta-analysis. medRxiv, 2021.04.26.21256155. https://doi.org/10.1101/2021.04.26.21256155
   Google Scholar
• Daniels, J., Medina-Marino, A., Glockner, K., Grew, E., Ngcelwane, N., & Kipp, A. (2021). Masculinity, resources, and retention in care: South African men’s behaviors and experiences while engaged in TB care and treatment. Social Science & Medicine, 270, 113639. https://doi.org/10.1016/j.socscimed.2020.113639
   PubMed Web of Science ®Google Scholar
• Egelund, E. F., & Bucciarelli, A. L. (2022). Art and the fight against tuberculosis. JAMA, 328(6), 509–510. https://doi.org/10.1001/jama.2021.24029
   PubMed Web of Science ®Google Scholar
• Ganiger, A., Patil, L., & Mrudula, N. (2019). Evaluation of serum electrolyte status among normal healthy individuals and newly diagnosed cases of pulmonary TB in tertiary care hospital in bidar: An observational study. Indian Journal of Medical Biochemistry, 23(3), 316–319. https://doi.org/10.5005/jp-journals-10054-0111
   Google Scholar
• Garg, N., & Lee, Y. I. (2020). Reactivation TB with severe COVID-19. CHEST, 158(4), A777. https://doi.org/10.1016/j.chest.2020.08.724
   Google Scholar
• Goovaerts, O., Massinga-Loembé, M., Ondoa, P., Ceulemans, A., Worodria, W., Mayanja-Kizza, H., Colebunders, R., Kestens, L. & Group, the T.-I. S. (2020). Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS. PLoS One, 15(12), e0244800. https://doi.org/10.1371/journal.pone.0244800
   PubMed Web of Science ®Google Scholar
• Hayibor, K. M., Bandoh, D. A., Asante-Poku, A., & Kenu, E. (2020). Predictors of adverse TB treatment outcome among TB/HIV patients compared with non-HIV patients in the greater Accra regional hospital from 2008 to 2016. Tuberculosis Research and Treatment, 2020, 1–8. https://doi.org/10.1155/2020/1097581
   Google Scholar
• Hutchinson, J., Checkland, K., Gibson, J., Kontopantelis, E., & Sutton, M. (2023). Consequences of the closure of general practices: A retrospective cross-sectional study. British Journal of General Practice, 73(731), e399–e406. https://doi.org/10.3399/BJGP.2022.0501
   PubMed Web of Science ®Google Scholar
• Ikram, M., Naeem, M., Zahoor, M., Hanafiah, M. M., Oyekanmi, A. A., Ullah, R., Farraj, D. A. A., Elshikh, M. S., Zekker, I., & Gulfam, N. (2022). Correction: Ikram et al. Biological degradation of the azo dye basic orange 2 by escherichia coli: A sustainable and ecofriendly approach for the treatment of textile wastewater. Water 2022, 14, 2063. Water, 14(19), 2969. https://doi.org/10.3390/w14192969
   Web of Science ®Google Scholar
• Izudi, J., Tamwesigire, I. K., & Bajunirwe, F. (2020). Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: A retrospective cohort study. BMC Public Health, 20(1), 501. https://doi.org/10.1186/s12889-020-08646-0
   PubMed Web of Science ®Google Scholar
• Kebogile, M., & Elias, P. (2014). Why do patients refuse antiretroviral therapy before they complete tuberculosis treatment?: A qualitative enquiry Journal of AIDS and HIV Research, 6(2), 33–38. https://doi.org/10.5897/JAHR2013.0284
   Google Scholar
• Khachadourian, V., Truzyan, N., Harutyunyan, A., Petrosyan, V., Davtyan, H., Davtyan, K., van den Boom, M., & Thompson, M. E. (2020). People–centred care versus clinic–based DOT for continuation phase TB treatment in Armenia: A cluster randomized trial. BMC Pulmonary Medicine, 20(1), 105. https://doi.org/10.1186/s12890-020-1141-y
   PubMed Web of Science ®Google Scholar
• Kintu, T. M., Mwanahamisi, B. S., Muwanguzi, M., Kyagambiddwa, T., Miiro, E., Tishekwa, N., Lodiong, L. J. D., Timbiine, A. K., Tumukunde, P., Baluku, J. B., & Nuwagira, E. (2023). Unfavorable treatment outcomes among patients with drug-resistant TB in Uganda. The International Journal of Tuberculosis and Lung Disease, 27(4), 291–297. https://doi.org/10.5588/ijtld.22.0638
   PubMed Web of Science ®Google Scholar
• Lungu, P. S., Kabaso, M. E., Mihova, R., Silumesii, A., Chisenga, T., Kasapo, C., Mwaba, I., Kerkhoff, A. D., Muyoyeta, M., Chimzizi, R., & Malama, K. (2022). Undernotification and underreporting of tuberculosis in Zambia: A national data quality assessment. BMC Health Services Research, 22(1), 1074. https://doi.org/10.1186/s12913-022-08431-2
   PubMed Web of Science ®Google Scholar
• Medina-Marino, A., Bezuidenhout, D., Ngcelwane, N., Cornell, M., Wainberg, M., Beyrer, C., Bekker, L.-G., & Daniels, J. (2022). Qualitative identification of intervention preferences to support men’s engagement and retention in TB care in South Africa. American Journal of Men's Health, 16(5), 155798832211293. https://doi.org/10.1177/15579883221129349
   Web of Science ®Google Scholar
• Meseret Tadele, M., Tizazu, G., Temesgen Denekew, H., & Tesfa Gebeyehu, M. (2022). Successful tuberculosis treatment outcome in east gojjam zone, Ethiopia: Cross-sectional study design. Alexandria Journal of Medicine, 58(1), 60–68. https://doi.org/10.1080/20905068.2022.2090064
   Web of Science ®Google Scholar
• MOH. (2016, November). ZMB-CH-43-01-PLAN-STRATEGY-2018-eng-TB-Zambia-National-TB-Strategic-Plan-2017-2021.pdf. https://platform.who.int/docs/default-source/mca-documents/policy-documents/plan-strategy/ZMB-CH-43-01-PLAN-STRATEGY-2018-eng-TB-Zambia-National-TB-Strategic-Plan-2017-2021.pdf.
   Google Scholar
• Murphy, M. E., Wills, G. H., Murthy, S., Louw, C., Bateson, A. L. C., Hunt, R. D., McHugh, T. D., Nunn, A. J., Meredith, S. K., Mendel, C. M., Spigelman, M., Crook, A. M., Gillespie, S. H., Diacon, A., Hanekom, M., Venter, A., Dawson, R., Narunsky, K., & Mtafya, B. &  … for the REMoxTB consortium. (2018). Gender differences in tuberculosis treatment outcomes: A post hoc analysis of the REMoxTB study. BMC Medicine, 16(1), 189. https://doi.org/10.1186/s12916-018-1169-5
   PubMedGoogle Scholar
• Nanzaluka, F. H., Chibuye, S., Kasapo, C. C., Langa, N., Nyimbili, S., Moonga, G., Kapata, N., Kumar, R., & Chongwe, G. (2019). Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: A secondary analysis of routine surveillance data. Pan African Medical Journal, 32, 159. https://doi.org/10.11604/pamj.2019.32.159.18472
   PubMed Web of Science ®Google Scholar
• Nwene, E. K. (2016). Tuberculosis and gender in Nigeria, Sex differences in diagnosis and treatment outcome of TB and TB HIV infected patients. TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 4(4), 388–395. https://doi.org/10.21522/TIJPH.2013.04.04.Art035
   Google Scholar
• Obadire, S. O., Mitsan, O., Ige, I. P., Oke, O. C., & Odewusi, F. O. (2022). Current innovations in medical laboratory diagnosis of tuberculosis. Sokoto Journal of Medical Laboratory Science, 7(3), 60–70. https://doi.org/10.4314/sokjmls.v7i3.7
   Google Scholar
• Rosenfeld, G., Gabrielian, A., Wang, Q., Gu, J., Hurt, D. E., Long, A., & Rosenthal, A. (2021). Radiologist observations of computed tomography (CT) images predict treatment outcome in TB portals, a real-world database of tuberculosis (TB) cases. PLoS One, 16(3), e0247906. https://doi.org/10.1371/journal.pone.0247906
   PubMed Web of Science ®Google Scholar
• Shete, P. B., & Kahn, J. G. (2019). Economic analyses to inform public health decision-making for tuberculosis: The role of understanding implementation. BMC Medicine, 17(1), 224. https://doi.org/10.1186/s12916-019-1468-5
   PubMed Web of Science ®Google Scholar
• Taye, G., Defar, A., Taddele, T., Bekele, A., Getachew, T., Teklie, H., Gonfa, G., Getnet, M., Tadesse, M., & Demissie, M. (2018). Treatment outcome and associated factors among TB patients in Ethiopia: Hospital-based retrospective study. American Journal of Epidemiology and Infectious Disease, 6(1), 14–19. https://doi.org/10.12691/ajeid-6-1-3
   Google Scholar
• Tiberi, S., Vjecha, M. J., Zumla, A., Galvin, J., Migliori, G. B., & Zumla, A. (2021). Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. International Journal of Infectious Diseases, 113, S96–S99. https://doi.org/10.1016/j.ijid.2021.02.067
   PubMed Web of Science ®Google Scholar
• Tok, P. S. K., Liew, S. M., Wong, L. P., Razali, A., Loganathan, T., Chinna, K., Ismail, N., & Kadir, N. A. (2020). Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS One, 15(4), e0231986. https://doi.org/10.1371/journal.pone.0231986
   PubMed Web of Science ®Google Scholar
• Uakarn, C., Chaokromthong, K., & Sintao, N. (2021). Sample Size Estimation using Yamane and Cochran and Krejcie and Morgan and Green Formulas and Cohen Statistical Power Analysis by G*Power and Comparisons.
   Google Scholar
• Uplekar, M., & Atre, S. (2021). Health systems and tuberculosis control. In G. B. Migliori, & M. C. Raviglione (Eds.), Essential tuberculosis (pp. 367–373). Springer International Publishing. https://doi.org/10.1007/978-3-030-66703-0_40.
   Google Scholar
• Vaghela, J. F., & Mangal, A. (2020). TB outcome of DOTS category I TB cases started on Re-treatment with category II regimen during the years 2002 to 2015, in a slum in Delhi. Journal of Communicable Diseases, 51(4), 62–68. (E-ISSN: 2581-351X & P-ISSN: 0019-5138). https://doi.org/10.24321/0019.5138.201938
   Google Scholar
• Water, B. J. v. d., Fulcher, I., Cilliers, S., Meyer, N., Wilson, M., Young, C., Gaunt, B., & Roux, K. l. (2022). Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in eastern cape, South Africa: A retrospective cohort study. PLoS One, 17(4), e0266082. https://doi.org/10.1371/journal.pone.0266082
   PubMed Web of Science ®Google Scholar
• WHO. (2013). Definitions and reporting framework for tuberculosis – 2013 revision: Updated December 2014 and January 2020. In Définitions et cadre de notification pour la tuberculose – révision 2013. World Health Organization. https://apps.who.int/iris/handle/10665/79199.
   Google Scholar
• WHO. (2023a, April 21). Tuberculosis (TB). https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
   Google Scholar
• WHO. (2023b, August 17). Tuberculosis (TB). WHO | Regional Office for Africa. https://www.afro.who.int/health-topics/tuberculosis-tb.
   Google Scholar
• Yusmaniar, Y., & Kurniawan, A. H. (2020). Medication adherence to successful tuberculosis treatment outcome among TB/HIV patient at prof. Dr. Sulianti saroso infectious disease hospital. Pharmacology and Clinical Pharmacy Research, 5(3), 98. https://doi.org/10.15416/pcpr.v5i3.29166
   Google Scholar
• Zhang, H., Ehiri, J., Yang, H., Tang, S., & Li, Y. (2016). Impact of community-based DOT on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLoS One, 11(2), e0147744. https://doi.org/10.1371/journal.pone.0147744
   PubMed Web of Science ®Google Scholar